TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 42.49%-8.02M | 47.64%-32.29M | 45.31%-13.94M | 13.52%-61.68M | -4.79%-25.49M | -134.00%-71.32M | -83.20%-24.33M | 40.01%-30.48M | -24.56%-13.28M | -480.41%-50.8M |
Profit adjustment | ||||||||||
Attributable subsidiary (profit) loss | -1,000.00%-36K | 988.71%675K | --4K | --62K | ---- | ---- | --454K | ---- | ---- | ---- |
Impairment and provisions: | 232.10%1.61M | -56.94%2.13M | -40,500.00%-1.22M | -69.55%4.95M | ---3K | 109.64%16.27M | ---- | 40.96%7.76M | -165.18%-73K | 1,404.74%5.51M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --2.68M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | 634.52%1.05M | -15.87%1.94M | -6,466.67%-197K | 2.13%2.31M | ---3K | -46.95%2.26M | ---- | 9,572.73%4.26M | ---17K | -36.23%44K |
-Other impairments and provisions | 154.46%556K | 703.13%193K | ---1.02M | -100.23%-32K | ---- | 299.77%14.01M | ---- | -35.83%3.51M | -150.00%-56K | 1,212.42%5.46M |
Asset sale loss (gain): | ---- | -387.69%-374K | ---- | -42.73%130K | ---- | 305.36%227K | ---- | 212.00%56K | ---- | -66.67%-50K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -387.69%-374K | ---- | -42.73%130K | ---- | 305.36%227K | ---- | 212.00%56K | ---- | -66.67%-50K |
Depreciation and amortization: | -56.84%1.37M | 2.23%5.86M | 9.52%3.17M | 20.48%5.74M | 53.97%2.89M | 4.78%4.76M | -21.76%1.88M | -8.88%4.54M | 6.10%2.4M | 62.18%4.99M |
-Depreciation | ---- | ---- | ---- | ---- | -30.07%1.36M | ---- | 10.86%1.95M | ---- | 4.58%1.76M | ---- |
-Amortization of intangible assets | -57.95%111K | 0.00%223K | 137.84%264K | 0.00%223K | 0.00%111K | 0.00%223K | -0.89%111K | 0.00%223K | 0.00%112K | 28.16%223K |
-Other depreciation and amortization | -176.09%-381K | -1.15%-617K | 43.67%-138K | -19.37%-610K | 2.78%-245K | -4.50%-511K | -3.70%-252K | 2.00%-489K | 4.33%-243K | 4.41%-499K |
Financial expense | 97.26%2.3M | 130.67%3.06M | 72.23%1.17M | 4.24%1.33M | 15.53%677K | 1,643.84%1.27M | 1,262.79%586K | -78.47%73K | -41.10%43K | 99.41%339K |
Special items | --923K | 3.45%3.42M | ---- | -70.08%3.31M | -84.42%1.93M | 185.42%11.06M | 1,136.70%12.37M | -73.55%3.87M | -83.10%1M | 87.98%14.65M |
Operating profit before the change of operating capital | 82.85%-1.86M | 62.07%-17.51M | 45.89%-10.82M | -22.33%-46.16M | -121.19%-20M | -166.28%-37.73M | 8.75%-9.04M | 44.15%-14.17M | -366.57%-9.91M | -1,484.18%-25.37M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -37.04%51K | -98.26%81K | 215.71%81K | 212.29%4.64M | 96.25%-70K | -409.11%-4.13M | -420.33%-1.87M | -3,790.91%-812K | -2,661.54%-359K | 136.67%22K |
Accounts receivable (increase)decrease | -864.01%-25.52M | 42.17%-3.83M | 308.75%3.34M | -101.95%-6.63M | 77.29%-1.6M | -128.12%-3.28M | -145.24%-7.05M | 64,961.11%11.68M | 118.23%15.57M | 99.91%-18K |
Accounts payable increase (decrease) | -39.96%54.68M | 234.75%3.96M | 1,191.20%91.06M | -127.54%-2.94M | ---8.35M | 164.84%10.66M | ---- | ---16.43M | ---- | ---- |
prepayments (increase)decrease | 96.47%-2.98M | 552.25%14M | -17,753.35%-84.38M | -1,054.85%-3.1M | 105.52%478K | -103.15%-268K | -146.48%-8.66M | 154.30%8.52M | 161.04%18.63M | -173.86%-15.68M |
Special items for working capital changes | 116.56%5.31M | -689.88%-32.48M | ---32.04M | -330.58%-4.11M | ---- | -108.32%-955K | ---- | -63.50%11.48M | ---- | 260.19%31.45M |
Cash from business operations | 190.58%29.68M | 38.60%-35.79M | -10.92%-32.77M | -63.20%-58.29M | -10.99%-29.54M | -14,217.79%-35.72M | -211.22%-26.62M | 102.63%253K | 691.59%23.93M | -13.38%-9.6M |
Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3M | ---- | ---- |
Other taxs | -62.77%-153K | -234.51%-152K | ---94K | 128.32%113K | ---- | -253.10%-399K | ---- | 49.33%-113K | ---- | 4.70%-223K |
Special items of business | ---- | ---- | ---- | ---- | -8,333.33%-3.29M | ---- | 99.68%-39K | ---- | 38.30%-12.02M | ---- |
Net cash from operations | 189.86%29.53M | 38.22%-35.94M | -0.10%-32.86M | -61.08%-58.18M | -23.16%-32.83M | -1,164.16%-36.12M | -323.78%-26.65M | 70.93%-2.86M | 150.63%11.91M | -12.89%-9.83M |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | 108.25%140K | -72.56%-1.96M | ---1.7M | 36.83%-1.14M | ---- | ---1.8M | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | 2,385.19%2.01M | ---- | --81K | ---- | ---- | ---- | ---- | ---- | 0.00%50K |
Purchase of fixed assets | 92.58%-108K | -20.51%-4.84M | -7.22%-1.46M | 63.57%-4.01M | 84.24%-1.36M | -738.20%-11.01M | -2,196.80%-8.61M | 57.10%-1.31M | 76.58%-375K | -78.39%-3.06M |
Acquisition of subsidiaries | ---- | ---- | ---- | --20K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---1.8M | ---- | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | --2.4M | ---- | ---- | ---- |
Net cash from investment operations | 101.02%32K | 5.23%-4.78M | -132.28%-3.15M | 60.61%-5.05M | 83.07%-1.36M | -875.19%-12.81M | -2,036.80%-8.01M | 56.39%-1.31M | -106.08%-375K | 22.64%-3.01M |
Net cash before financing | 182.08%29.56M | 35.58%-40.73M | -5.34%-36.01M | -29.21%-63.23M | 1.39%-34.19M | -1,073.12%-48.93M | -400.51%-34.67M | 67.52%-4.17M | 166.46%11.54M | -1.90%-12.84M |
Cash flow from financing activities | ||||||||||
New borrowing | -82.85%10.29M | --60M | 3,900.00%60M | ---- | -90.00%1.5M | -25.00%15M | --15M | --20M | ---- | ---- |
Refund | ---40.29M | ---30M | ---- | ---- | ---- | ---- | ---- | 87.24%-335K | ---335K | 30.92%-2.63M |
Issuing shares | --15.08M | ---- | ---- | ---- | ---- | --118.33M | ---- | ---- | ---- | ---- |
Interest paid - financing | -6,159.26%-1.69M | -927.72%-1.04M | 63.01%-27K | 86.13%-101K | 87.54%-73K | -897.26%-728K | -1,262.79%-586K | 78.47%-73K | ---43K | -208.18%-339K |
Dividends paid - financing | ---- | ---52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---1.9M | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.7M |
Net cash from financing operations | -128.30%-16.9M | 1,219.28%26.89M | 27,992.99%59.69M | -101.86%-2.4M | -101.49%-214K | 600.61%129.43M | 1,310.46%14.34M | 396.25%18.47M | -47.57%-1.19M | -128.31%-6.24M |
Effect of rate | 0.69%-576K | 77.79%-339K | -3.02%-580K | -1,512.96%-1.53M | -134.58%-563K | -84.46%108K | -3,900.00%-240K | 386.01%695K | 87.23%-6K | 132.95%143K |
Net Cash | -46.52%12.66M | 78.91%-13.84M | 168.84%23.68M | -181.53%-65.63M | -69.26%-34.4M | 462.81%80.5M | -296.34%-20.32M | 174.98%14.3M | 157.00%10.35M | -302.31%-19.08M |
Begining period cash | -29.86%33.31M | -58.58%47.49M | -58.58%47.49M | 236.82%114.64M | 236.82%114.64M | 78.78%34.04M | 78.78%34.04M | -49.86%19.04M | -49.86%19.04M | 31.04%37.97M |
Cash at the end | -35.69%45.4M | -29.86%33.31M | -11.41%70.59M | -58.58%47.49M | 491.38%79.68M | 236.82%114.64M | -54.15%13.47M | 78.78%34.04M | 48.67%29.38M | -49.86%19.04M |
Cash balance analysis | ||||||||||
Cash and bank balance | -35.69%45.4M | ---- | --70.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | -35.69%45.4M | ---- | --70.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.